I'm not expecting a NR. However, a second licensing deal is imminent, Phase 1 Renal trial top-line data is expected soon, an announcement of second molecule IND filing is expected soon, and an announcement of plans for complement disease/PNH trial are all things that are possible. It's going to be an exciting 2 months with the NY and London R&D Updates tomorrow and Monday, the "notice of meeting and management information circular containing the matters to be considered at the [AGM] meeting" being communicated on or before November 15th, and the AGM on December 15th. Meetings with the FDA are happening by the end of year that impact BETonMACE and future BETonRENAL trials. RVX will be meeting with their renal clinical advisory board in November to finalize their study design for BETonRENAL. Lots of good stuff going on. A lack of a NR tomorrow does not mean much. Tomorrow may be exactly what the event is called....a Research and Development Update. We'll find out soon enough!

BearDownAZ